So we’re designing a bioreactor that creates a lot of turbulence in the liquid to keep those bubbles small and to keep the gases moving around. We also have to consider that some of the gases we’re using are flammable, so we have to design with that in mind as well. And finally, we’re also thinking about how we can make the process as energy efficient as possible.
AFN: What potential applications do you see for your tailored fats?
SN: We’re initially targeting the food industry, but we’re also looking at applications in cosmetics and personal care products, and potentially pharmaceuticals. We’re particularly excited about the potential for our products in plant-based meats and dairy alternatives, as well as in confectionery and baked goods.
AFN: What’s next for Circe?
SN: We’re currently working on scaling up our technology to demonstrate that we can produce our tailored fats at commercial scale. We’re also exploring partnerships with food and ingredient companies to bring our products to market.
Ultimately, our goal is to revolutionize the way fats and oils are produced, making them more sustainable, affordable, and scalable than ever before.
AFN would like to thank Dr. Shannon Nangle for taking the time to speak with us and share more about Circe’s innovative approach to gas fermentation and sustainable fat production.
For more information about Circe, visit their website here.
Unlocking the Potential of Gas Fermentation: A Conversation with Circe Bioscience
In the world of biotechnology, a groundbreaking innovation is taking shape – gas fermentation. Circe Bioscience, a pioneer in this field, is on a mission to revolutionize the production of fats using aerobic gas fermentation. We sat down with the founder and CEO, Sarah Nguyen, to discuss the current state of affairs and the exciting journey ahead.
The Pilot Plant: A Unique Endeavor
At Circe Bioscience, the focus is on pushing the boundaries of gas fermentation technology. The company has successfully raised funds and built a pilot plant that stands out for its aerobic gas fermenter, which is food-grade and one of the largest of its kind globally. This pilot plant can operate in multiple gas fermentation modes, including loop, air lift, bubble column, and agitated, showcasing the versatility and scalability of the technology.
According to Sarah Nguyen, “No one has scaled aerobic gas fermentation beyond a few hundred liters, so we needed to explore different technologies to determine the most effective approach. The pilot plant allows us to test and optimize various methods to maximize efficiency.”
Fueling Growth: Funding and Expansion Plans
Circe Bioscience has been successful in securing both dilutive and non-dilutive funding, with a total of $16 million raised to date. The company is currently in the process of raising a Series A round to support its next phase of growth. The focus is on building a demo-scale plant with a capacity of 150 tons, and Circe Bioscience is actively seeking offtake partners to justify the construction of this plant.
Sarah Nguyen highlights the importance of demonstrating the economic viability of the technology to attract venture capital investment. She states, “Our goal is to show that the economics make sense for potential investors. We are looking for partners who believe in our mission and see the immense potential of gas fermentation in the food industry.”
Market Potential: Meeting the Demand for Sustainable Fats
While competing with crude palm oil may not be feasible, Circe Bioscience is witnessing growing interest in producing palm oil fractions and dairy fats using its platform. The company is poised to cater to the market demand for sustainable and environmentally friendly fats, offering a compelling alternative to traditional sources.
Challenges and Opportunities
As with any innovative technology, there are challenges to overcome. Sarah Nguyen expresses her concern about securing the necessary funding to demonstrate the scalability of the technology. She emphasizes the importance of educating both foodtech and climate tech investors about the unique value proposition of gas fermentation.
Regulatory considerations also play a crucial role in the development of fats produced through gas fermentation. Circe Bioscience is committed to ensuring compliance with food safety standards and is working closely with consultants to navigate the regulatory landscape. The labeling of these fats is still under discussion, with possibilities such as “cultured oil” being considered.
Looking Towards the Future
As Circe Bioscience continues its journey towards commercialization, the company remains focused on innovation, sustainability, and growth. With a strong foundation in place and a clear vision for the future, Circe Bioscience is poised to make a significant impact in the food industry through gas fermentation technology.
For more insights on the potential of gas fermentation in food and feed production, check out our related articles:
- Protein from air startup Solar Foods plans to go public
- Can gas fermentation deliver on its green promise for food and feed? In conversation with Calysta
Join us in following the journey of Circe Bioscience as they pave the way for a sustainable and innovative future in the food industry.
